| Literature DB >> 32557475 |
Marco Antonio Alvarez-Gonzalez1,2,3, Miguel Ángel Pantaleón Sánchez1,2, Belén Bernad Cabredo4, Ana García-Rodríguez5, Santiago Frago Larramona6, Oscar Nogales7, Pilar Díez Redondo8, Ignasi Puig Del Castillo9, Cristina Romero Mascarell10, Noemí Caballero11, Iván Romero Sánchez-Miguel12, Rocío Pérez Berbegal1, Domingo Hernández Negrín13, Gema Bujedo Sadornill4, Alicia Pérez Oltra5, Gemma Casals Urquiza1, Jaume Amorós Martínez14, Agustín Seoane Urgorri1,3, Inés Ana Ibáñez Zafón1, Antonio Z Gimeno-García13.
Abstract
BACKGROUND: The most important predictor of unsuccessful bowel preparation is previous failure. For those patients with previous failure, we hypothesized that a nurse-led educational intervention by telephone shortly before the colonoscopy appointment could improve cleansing efficacy.Entities:
Year: 2020 PMID: 32557475 PMCID: PMC7591317 DOI: 10.1055/a-1178-9844
Source DB: PubMed Journal: Endoscopy ISSN: 0013-726X Impact factor: 10.093
Fig. 1 Flow-chart of the study. ITT, intention to treat; PP, per protocol.
Baseline characteristics of the patients regarding the initial failed colonoscopy.
| Variable | Control (n = 329) | Telephone (n = 322) |
|
| Interval, median (IQR), days | 30 (44.5) | 30 (39) | 0.92 |
| Age, median (IQR), years | 63.7 (17.6) | 64.4 (15.7) | 0.38 |
| Male sex, n (%) | 185 (56.2) | 179 (55.6) | 0.87 |
| BMI, median (IQR) | 27.1 (5.3) | 26.7 (7.1) | 0.93 |
| Diabetes mellitus, n (%) | 79 (24.0) | 61 (18.9) | 0.12 |
| Abdominal/pelvic surgery, n (%) | 138 (41.9) | 135 (41.9) | 0.99 |
| Partial colectomy, n (%) | 35 (10.6) | 30 (9.3) | 0.52 |
| Constipation, n (%) | 123 (37.4) | 125 (38.8) | 0.78 |
| Tricyclic antidepressants, n (%) | 28 (8.5) | 32 (9.9) | 0.53 |
| Calcium blockers, n (%) | 27 (8.2) | 20 (6.2) | 0.33 |
| Opiates, n (%) | 14 (4.3) | 17 (5.3) | 0.54 |
| Illiteracy, n (%) | 7 (2.1) | 6 (1.9) | 0.81 |
| ASA class, n (%) | 0.04 | ||
I | 133 (40.4) | 100 (31.1) | |
II | 171 (52.0) | 193 (59.9) | |
III | 25 (7.6) | 29 (9.0) | |
| Indication, n (%) | 0.81 | ||
Screening | 87 (26.4) | 85 (26.4) | |
Surveillance | 96 (29.2) | 95 (29.5) | |
Diagnostic | 145 (44.1) | 142 (44.1) | |
| Referring physician, n (%) | 0.31 | ||
Gastroenterologist | 76 (23.1) | 74 (23.0) | |
Primary care | 187 (56.8) | 199 (61.8) | |
Other specialties | 65 (19.8) | 49 (15.2) | |
| First colonoscopy, n (%) | 143 (43.5) | 155 (48.1) | 0.13 |
| Laxative, n (%) | 0.51 | ||
MCSP | 94 (28.6) | 87 (27.0) | |
PEG + ascorbate, 2 L | 99 (30.1) | 82 (25.5) | |
PEG ,4 L | 128 (38.9) | 143 (44.4) | |
| Dosing, n (%) | 0.72 | ||
Split dose 2 days | 208 (63.2) | 207 (64.3) | |
Split dose same day | 33 (10.0) | 28 (8.7) | |
Day before | 85 (25.8) | 86 (26.7) | |
| Interval ≤ 5 hours, n (%) | 174 (52.9) | 164 (50.9) | 0.53 |
| Instructions, n (%) | 0.56 | ||
Oral | 30 (9.1) | 31 (9.6) | |
Written | 184 (55.9) | 183 (56.8) | |
Oral and written | 112 (34.3) | 108 (33.5) | |
| Morning schedule, n (%) | 235 (71.4) | 216 (67.1) | 0.30 |
| Medical education provider, n (%) | 0.54 | ||
Nurse | 93 (28.3) | 87 (27.0) | |
Physician | 101 (30.7) | 104 (32.3) | |
Secretary | 133 (40.4) | 131 (40.7) | |
| Complete colonoscopy rate, n (%) | 170 (51.7) | 165 (51.2) | 0.91 |
IQR, interquartile range; BMI, body mass index; ASA, American Society of Anesthesiologists; MCSP, magnesium citrate plus sodium picosulfate; PEG, polyethylene glycol.
Medical conditions associated with poor bowel cleansing but affecting < 5 % of patients (cirrhosis, stroke, severe renal impairment, Parkinson disease or dementia) are not represented.
Outcome measures in the intention-to-treat and per-protocol analyses.
| Variable | Control (n = 329) | Telephone (n = 322) | ARD (95 %CI) |
|
| Successful bowel preparation, n/N (%) | ||||
ITT | 237/329 (72.0) | 249/322 (77.3) | 5.3 (–1.4 to 12.0) | 0.12 |
PP | 237/329 (72.0) | 223/267 (83.5) | 11.5 (4.9 to 18.1) | 0.001 |
| Colonoscopy attendance, n/N (%) | ||||
ITT | 302/329 (91.8) | 303/322 (94.1) | 2.3 (–1.6 to 6.2) | 0.25 |
PP | 302 /329 (91.8) | 263 /267 (98.5) | 6.7 (3.4 to 10.0) | 0.001 |
| BBPS score ≥ 2 in all segments, n/N (%) | ||||
ITT | 237/302 (78.5) | 249/303 (82.2) | 3.7 (–2.6 to 10.0) | 0.25 |
PP | 237/302 (78.5) | 223/263 (84.8) | 6.3 (0.0 to 12.7) | 0.05 |
| Right colon BBPS score ≥ 2, n/N (%) | ||||
ITT | 235/284 (82.7) | 242/284 (85.2) | 2.5 (–3.6 to 8.5) | 0.42 |
PP | 235/284 (82.7) | 218/248 (87.9) | 5.2 (–0.8 to 11.1) | 0.10 |
| Transverse colon BBPS score ≥ 2, n/N (%) | ||||
ITT | 255/290 (87.9) | 269/291 (92.4) | 4.5 (–0.3 to 9.3) | 0.07 |
PP | 255/290 (87.9) | 235/253 (92.9) | 5 (0.0 to 9.9) | 0.05 |
| Left colon BBPS score ≥ 2, n/N (%) | ||||
ITT | 259/301 (86.0) | 274/303 (90.4) | 4.4 (–0.7 to 9.5) | 0.10 |
PP | 259/301 (86.0) | 242/263 (92.0) | 6 (0.9 to 11.1) | 0.03 |
| Complete colonoscopy, n/N (%) | ||||
ITT | 265/302 (87.7) | 280/303 (92.4) | 4.7 (–0.1 to 9.4) | 0.06 |
PP | 265/302 (87.7) | 244/263 (92.8) | 5 (0.2 to 9.9) | 0.046 |
| Adherence to low-fiber diet, n/N (%) | ||||
ITT | 264/300 (88.0) | 256/302 (84.8) | –3.2 (–8.7 to 2.2) | 0.25 |
PP | 264/300 (88.0) | 222/262 (84.7) | –3.3 (–9.0 to 2.4) | 0.26 |
| Laxative intake > 75 %, n/N (%) | ||||
ITT | 294/301 (97.7) | 296/300 (98.7) | 1 (–1.1 to 3.1) | 0.36 |
PP | 294/301 (97.7) | 256/260 (98.5) | 0.8 (–1.5 to 3.1) | 0.50 |
|
Interval
| ||||
ITT | 232/277 (83.8) | 238/276 (86.2) | 2.5 (–3.5 to 8.4) | 0.42 |
PP | 232/277 (83.8) | 206/237 (86.9) | 3.2 (–2.9 to 9.3) | 0.31 |
ARD, absolute risk difference; CI, confidence interval; ITT, intention-to-treat population; PP, per-protocol population; BBPS, Boston Bowel Preparation Score.
Interval refers to the interval between the start of the last laxative intake and the colonoscopy.
Detected lesions.
| Variable | Control (n = 329) | Telephone (n = 322) |
|
| Mean adenoma per patient (95 %CI) | |||
ITT | 0.84 (0.66 to 1.03) | 1.14 (0.89 to 1.4) | 0.07 |
PP | 0.84 (0.66 to 1.03) | 1.1 (0.84 to 1.35) | 0.11 |
| Overall adenoma detection rate, n/N (%) | |||
ITT | 117/302 (38.7) | 130/303 (42.9) | 0.30 |
PP | 117/302(38.7) | 116/263 (44.1) | 0.20 |
| Proximal adenoma detection rate, n/N (%) | |||
ITT | 78/302 (25.8) | 94/303 (31.0) | 0.16 |
PP | 78/302 (25.8) | 85/263 (32.3) | 0.09 |
| Distal adenoma detection rate, n/N (%) | |||
ITT | 62/302 (20.5) | 82/303 (27.1) | 0.06 |
PP | 62/302 (20.5) | 71/263 (27.0) | 0.07 |
| Multiple adenoma (≥ 3), n/N (%) | |||
ITT | 29/302 (9.6) | 45/303 (14.9) | 0.049 |
PP | 29/302 (9.6) | 39/263 (14.8) | 0.06 |
| Overall serrated detection rate, n/N (%) | |||
ITT | 27/302 (8.9) | 45/303 (14.9) | 0.03 |
PP | 27/302 (8.9) | 40/263 (15.2) | 0.02 |
| Invasive neoplasia, n/N (%) | |||
ITT | 5/302 (1.7) | 6/303 (2.0) | 0.77 |
PP | 5/302 (1.7) | 5/263 (1.9) | 0.83 |
CI, confidence interval; ITT, intention-to-treat population; PP, per-protocol population.
Bowel preparation success by subgroups of risk factors.
| Variable | Control, n/N (%) | Telephone, n/N (%) | ARD (95 %CI) |
LR
|
Corrected
|
| Diabetes mellitus | 4.85 | 0.35 | |||
Yes | 52/79 (65.8) | 42/61 (68.9) | 3 (–12.6 to 18.0) | ||
No | 185/250 (74.0) | 207/261 (79.3) | 5.3 (–2.0 to 12.6) | ||
| Abdominal/pelvic surgery | 5.08 | 0.32 | |||
Yes | 99/138 (71.7) | 96/135 (71.1) | –0.6 (–11.3 to 10.0) | ||
No | 138/191 (72.3) | 153/187 (81.8) | 9.6 (1.1 to 17.9) | ||
| Constipation | 6.8 | 0.13 | |||
Yes | 83/123 (67.5) | 89/125 (71.2) | 3.7 (–7.7 to 15.0) | ||
No | 153/202 (75.7) | 159/196 (81.1) | 5.4 (–2.7 to 13.4) | ||
| Indication | 17.22 | 0.007 | |||
Screening | 71/87 (81.6) | 71/85 (83.5) | 1.9 (–9.6 to 13.3) | ||
Surveillance | 76/96 (79.2) | 71/95 (74.7) | –4.4 (–16.3 to 7.5) | ||
Symptoms | 89/145 (61.4) | 107/142 (75.4) | 14 (3.2 to 24.3) | ||
ARD, absolute risk difference; CI, confidence interval; LR, likelihood ratio.
Chi-squared test.